Spinach Recall Update As FDA Sets Highest Risk Level
The recall of Solata Foods LLC spinach products has been categorized as class one, which indicates the highest level of ...
Tomato Sauce Recall Update as FDA Sets Risk Level
Customers who have purchased the recalled Tomato Basil Sauce can return it to the place of purchase for a full refund. For ...
The FDA upgrades the recent chia seed recall to a "class 1 risk classification"
The original FDA announcement, dated May 2024, reads: "Natural Sourcing International is initiating a voluntary recall of one ...
US FDA declines to approve Novo Nordisk's weekly insulin
The U.S. Food and Drug Administration has declined to approve Novo Nordisk's weekly insulin in patients with diabetes, the ...
US FDA flags shortage of Becton Dickinson's blood test tubes
The U.S. Food and Drug Administration issued an alert on Wednesday to laboratories and healthcare providers of a shortage of ...
Muffin Recall Updated Nationwide As FDA Sets Risk Level
The U.S. Food and Drug Administration (FDA) has updated the classification of a recall of ALDI's Bakeshop Chocolate Chip ...
FDA warns WA residents of microdosing products linked to severe illness
The FDA says anyone with “Diamond Shruumz" products should destroy and discard them after multiple people developed severe ...
From Dr. Oz to heart valves: A tiny device charted a contentious path through the FDA
Since MitraClip, a device whose inventors include former TV personality and Pa. Senate candidate Dr. Mehmet Oz, won FDA ...
FiercePharma11h
FDA proposes cell and gene therapy site tours to help regulators learn from industry
It's no secret that cell and gene therapies have faced manufacturing hurdles as the advanced medicines have become ...
STAT23h
Top FDA officials weighing regulation of ultra-processed foods, internal documents show
Two senior FDA officials met multiple times in February to discuss regulating these edible industrial creations, such as ...
TCTMD11h
FDA to Add New Diversity Requirements for Certain Clinical Studies
Requiring sponsors to submit diversity action plans is a good first step to greater representation in trials, experts say.
Targeted Oncology13h
FDA Receives IND Submission for Phase 1/2 Trial of Silmitasertib in Solid Tumors
The FDA has received the submission of an investigational new drug application for a phase 1/2 trial evaluating the ...